BIO.News Newsletter

Before you move from the home office to the backyard for the long weekend, read up on this important law that’s making breakthrough treatments possible, in around 670 words, or 3 minutes, 20 seconds. Good Day BIO is taking a quick break for Memorial Day. We’ll be in touch if there’s major breaking news, but otherwise, we’ll resume regular publication on Tuesday, May 26.

Even with #WFH, there’s still a lot happening on Capitol Hill—and yesterday, a Senate Committee took an important step forward for the bioeconomy. More on that, plus an update from Jim on how the SEC is providing relief to small biotechs on the COVID-19 frontlines, in around 720 words, under 4 minutes.

Lots of questions today—on vaccine manufacturing and distribution, on whether we should get excited (yet) about potential vaccine candidates, and on whether bats are to blame for the pandemic. We have some answers, as well as the latest news from Washington (there's a lot!) in around 900 words, 4 minutes, 30 seconds.

It’s a busy Tuesday, and we’ve got a quick hit today, with around 500 words (2 and a half minutes) on an exciting new project with the BBC and what you might have missed in Washington.

We’re kicking off the week with a fascinating new episode of the I AM BIO Podcast about one company searching for a superstar antibody that could help us understand and beat COVID-19. And we’ve also got more from Cargill and Capitol Hill. Here’s your Monday news, in 880 words, about 4 minutes, 20 seconds.

It’s Friday, but we’ve got a jam-packed issue today: news on USDA’s new rule on food biotech, a new resource for learning about global COVID-19 collaborations, plus two must-watch videos. Here are just under 1,000 words, just under 5 minutes. P.S. Don’t miss the latest episode of the I AM BIO Podcast featuring Christi Shaw, CEO of Kite, Gilead’s cell therapy company, about CAR T and why “cancer doesn’t stop in the crisis.” Listen at www.bio.org/podcast or wherever you get your podcasts.

We’re dedicating today’s issue to our exciting news: immunologist Dr. Michelle McMurry-Heath will take the reins as BIO’s President and CEO on June 1. Get to know her and how her global leadership and commitment to innovation and patients will drive our industry forward at this critical moment in history, in 620 words, 3 minutes.

If you’re just waking up, BIO’s Phyllis Arthur joined WJLA, Washington DC’s ABC affiliate, to discuss the industry’s response to COVID-19. Watch the segment here. In other news, we’re recognizing Hepatitis Awareness Month and the biotech industry’s work on another “C”-named disease, as well as a llama (!!) who might help us beat COVID-19, in 650 words, around 3 minutes, 15 seconds.

ICYMI: Last night, Centers for Medicare and Medicaid Services (CMS) took an important step forward for America’s seniors and the future of innovative CAR T-cell therapies. Here’s our take. We have an announcement, too: the launch of a cool new COVID-19 R&D tracker. There’s also been a lot of chatter on biofuels and the biobased economy—one of the most important tools available for getting the American economy back to full health. Here are 915 words, about 4 and a half minutes.

It's Monday...and National Twilight Zone Day. Of course it is. But for today, we're sticking with this theme by taking a look back when several researchers warned us about a future pandemic from a virus-like SARS—16 years ago. Here's a quick 500 words, under 3 minutes.